
News|Articles|September 1, 2026
5 Essential Capabilities for Decentralized Clinical Trials
Author(s)Quest Diagnostics
Advertisement
As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, enabling broader patient participation, increasing trial efficiency, and driving more inclusive, real-world data collection. However, the successful execution of DCTs requires more than just innovative technology—it demands a comprehensive strategy that addresses the unique challenges of decentralization.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
HHS Confirms Four Senior FDA Leaders, Including Agency's First-Ever AI Deputy Commissioner
2
How Elevated Cortisol Levels Can Impact Type II Diabetes Treatments
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
IBD's Most Persistent Gap: Q&A with Christian Thienel
5




